| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/12/2011 | US7923206 Method of determining a cellular response to a biological agent |
| 04/12/2011 | US7923205 Method for protecting personal information |
| 04/12/2011 | US7923204 Forward mutation assay based on 5-fluorouracil resistance |
| 04/12/2011 | US7923000 Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| 04/12/2011 | US7922971 Integrated meter for analyzing biological samples |
| 04/12/2011 | US7922893 System and method for preparing near-surface heavy oil for extraction using microbial degradation |
| 04/12/2011 | US7922483 Method of using a polynucleotide encoding 2.5-diketo-D-gluconic acid reductase |
| 04/12/2011 | CA2543846C Hcv replicons containing ns5b from genotype 2b |
| 04/12/2011 | CA2530297C Reagent stripe for test strip |
| 04/12/2011 | CA2529657C Test strip with slot vent opening |
| 04/12/2011 | CA2488775C Fcyriia transgenic animal model for autoimmune disease |
| 04/12/2011 | CA2460329C Method for sequencing nucleic acids |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 04/12/2011 | CA2428864C Method and device for collecting and stabilizing a biological sample |
| 04/12/2011 | CA2399475C Isolation of nucleic acid from stool samples and other biological materials which are rich in inhibitors |
| 04/12/2011 | CA2388363C Dna polymerase lambda and uses thereof |
| 04/12/2011 | CA2381037C Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2354054C Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 04/12/2011 | CA2228769C Method of purifying, stabilising or isolating nucleic acids contained in biological matter |
| 04/12/2011 | CA1341611C Interleukin-1 receptors |
| 04/07/2011 | WO2011041788A2 Turkey viral hepatitis virus and uses thereof |
| 04/07/2011 | WO2011041784A1 Methods for diagnosing and treating cancer |
| 04/07/2011 | WO2011041725A2 Schizophrenia treatment response biomarkers |
| 04/07/2011 | WO2011041695A1 Determination of methylation status of polynucleotides |
| 04/07/2011 | WO2011041611A1 Cofactors and methods for use for individuals |
| 04/07/2011 | WO2011041524A1 Methods for improving fertility and selectivity for desired offspring sex in artificial insemination |
| 04/07/2011 | WO2011041485A1 Methods for non-invasive prenatal ploidy calling |
| 04/07/2011 | WO2011041433A1 Methods for diagnosing and treating encephalitis or epilepsy |
| 04/07/2011 | WO2011041411A2 Method for detecting single nucleotide polymorphisms |
| 04/07/2011 | WO2011041308A1 Bcr-abl truncation mutations |
| 04/07/2011 | WO2011040971A2 Generation of modified polymerases for improved accuracy in single molecule sequencing |
| 04/07/2011 | WO2011040886A1 Methods and arrays for dna sequencing |
| 04/07/2011 | WO2011040885A1 A clinical method for genotyping large genes for mutations that potentially cause disease |
| 04/07/2011 | WO2011040882A2 Water-soluble silsesquioxanes as organic quantum dots for sensing and imaging |
| 04/07/2011 | WO2011040874A1 Testing system for determining hypoxia induced cellular damage |
| 04/07/2011 | WO2011040676A1 Method of identification with combined ligand-receptor biomolecule using surface topography of hybrid bio-inorganic molecule |
| 04/07/2011 | WO2011040612A1 Fluorescent molecule and method for detecting target nucleic acid |
| 04/07/2011 | WO2011040532A1 Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therein |
| 04/07/2011 | WO2011040525A1 Colon cancer marker and method for testing for colon cancer |
| 04/07/2011 | WO2011040475A1 Method for screening for salty taste control substance |
| 04/07/2011 | WO2011040421A1 Screening method |
| 04/07/2011 | WO2011039775A1 A modified method of agglutination to detect infections caused by microorganisms |
| 04/07/2011 | WO2011039757A2 Compositions and methods for prognosis of renal cancer |
| 04/07/2011 | WO2011039650A1 Method for the diagnosis/prognosis of age-related macular degeneration |
| 04/07/2011 | WO2011039612A1 Detection and use of antiviral resistance mutations |
| 04/07/2011 | WO2011039425A1 Method of preparing a reaction mixture and related products |
| 04/07/2011 | WO2011039359A2 Authentication method of dairy products |
| 04/07/2011 | WO2011039321A1 Method for detecting microorganisms |
| 04/07/2011 | WO2011038932A1 Haplotype of katiii gene |
| 04/07/2011 | WO2011038763A1 Method for biomolecular detection of human liver diseases compositions and kits used in said method |
| 04/07/2011 | WO2011038507A1 Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids |
| 04/07/2011 | WO2011038461A1 System and method for classification of patients |
| 04/07/2011 | WO2011018589A3 Reaction medium for methicillin-resistant staphylococcus aureus (mrsa) bacteria |
| 04/07/2011 | WO2011014083A3 Determination of the risk of distant metastases in surgically treated patients with non-small cell lung cancer in stage i-iiia |
| 04/07/2011 | WO2011002850A8 Methods of determining the presence and/or concentration of an analyte in a sample |
| 04/07/2011 | WO2010127342A3 Method of preparing autologous cells and method of use for therapy |
| 04/07/2011 | WO2010118016A3 Digital quantification of dna methylation |
| 04/07/2011 | WO2010117817A3 Methods for generating target specific probes for solution based capture |
| 04/07/2011 | WO2010091354A3 Akt tyrosine 176 phosphorylation cancer biomarker |
| 04/07/2011 | WO2010091296A3 Emx2 in cancer diagnosis and prognosis |
| 04/07/2011 | WO2010091049A3 Diagnosis and treatment of cancer |
| 04/07/2011 | WO2010091046A3 Systems and methods for high throughput, high fidelity, single molecule nucleic acid sequencing using time multiplexed excitation |
| 04/07/2011 | US20110083233 RICE BLAST SUSCEPTIBILITY GENE Pi21, RESISTANCE GENE pi21 AND USES THEREOF |
| 04/07/2011 | US20110083229 EG1117 And EG307 Polynucleotides And Uses Thereof |
| 04/07/2011 | US20110083224 Quantitative Trait Loci Associated With Soybean Cyst Nematode Resistance and Uses Thereof |
| 04/07/2011 | US20110083199 Non-Human Animal Model for Cardiovascular Disease Characterized by a Disrupted Fibulin-4 Gene |
| 04/07/2011 | US20110082563 Microscale multiple-fluid-stream bioreactor for cell culture |
| 04/07/2011 | US20110082549 Mineralized three-dimensional bone constructs formed from osteoblasts |
| 04/07/2011 | US20110082356 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
| 04/07/2011 | US20110082188 Gene expression profiling of inflammatory bowel disease |
| 04/07/2011 | US20110082180 Antimicrobial compounds |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 04/07/2011 | US20110082091 Method for Preclinical Testing of Immunomodulatory Drugs |
| 04/07/2011 | US20110082051 Substrates, systems and methods for analyzing materials |
| 04/07/2011 | US20110082050 Cystic fibrosis transmembrane conductance regulator gene mutations |
| 04/07/2011 | US20110082049 Method and system for automated image analysis in cancer cells |
| 04/07/2011 | US20110081688 Water-Soluble Rhodamine Dyes Conjugates |
| 04/07/2011 | US20110081676 Rapid detection of viable bacteria system and method |
| 04/07/2011 | US20110081675 Metabolic Biomarkers Of Drug-Induced Cardiotoxicity |
| 04/07/2011 | US20110081674 Continuous-flow deformability-based cell separation |
| 04/07/2011 | US20110081673 Diagnostic Gum for Screening Diabetes |
| 04/07/2011 | US20110081672 Process control of biotechnological processes |
| 04/07/2011 | US20110081671 Vascular markers in the remodeling of cardiac injury |
| 04/07/2011 | US20110081670 Luciferase-based assays |
| 04/07/2011 | US20110081664 Multipurpose microfluidic device for mimicking a microenvironment within a tumor |
| 04/07/2011 | US20110081659 Substrates for glycogen synthase kinase 3 enzymes and methods of use |
| 04/07/2011 | US20110081658 T1r3 binding assays |
| 04/07/2011 | US20110081657 Controlled platelet activation to monitor therapy of adp antagonists |
| 04/07/2011 | US20110081655 Nucleic acid analyzing device and nucleic acid analyzer |
| 04/07/2011 | US20110081654 Transcriptional profiling of stem cells and their multilineage differentiation |
| 04/07/2011 | US20110081653 High Spatial Resolution Imaging of a Structure of Interest in a Specimen |
| 04/07/2011 | US20110081652 Method of classifying gene expression strength in lung cancer tissues |
| 04/07/2011 | US20110081651 Egfr and kras mutations |
| 04/07/2011 | US20110081650 Free ngal as a biomarker for cancer |
| 04/07/2011 | US20110081649 Diagnosis, staging and monitoring of inflammatory bowel disease |
| 04/07/2011 | US20110081648 Methods for diagnosing peripheral neuropathy |
| 04/07/2011 | US20110081647 Nucleotide analogs |